Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 66
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
Intervalo de año de publicación
1.
Ig Sanita Pubbl ; 77(1): 414-425, 2021.
Artículo en Italiano | MEDLINE | ID: mdl-33883751

RESUMEN

OBJECTIVES: To evaluate the effectiveness and the frequency of use of a pulsed xenon ultraviolet light-emitting no-touch portable device (PX-UV), applied after perform current cleaning, in reducing environmental bacterial burden and the presence of pathogens on surfaces in the operating rooms at the Policlinico University Hospital of Foggia. DESIGN: Prospective before-and-after study with a follow up duration of four months, from May to August 2019. SETTING AND PARTICIPANTS: Two operating rooms of an Orthopaedic and a Neurosurgical ward in a 780-bed university hospital in the District of Foggia, Italy (about 600,000 inhabitants). MAIN OUTCOME MEASURES: According to the hygienic standards proposed by the Italian Workers Compensation Authority (ISPESL), the total and the average bacterial load and the presence of six pathogens were evaluated between pre- and post- PX-UV use combined with routine manual cleaning. RESULTS: The PX-UV system was applied at five distinct time points: t1: start of the experiment, t2: after 28 days, t3: after 13 days, t4: after 7 days, and t5: after 8 days (t2-t5: 28 days in total). About 16-min of PX-UV cycle showed significant reduction in the level of environmental contamination by decreasing the mean colony count by 87.5%, compliant with the standard (5< X ≤15 CFU per plat). Staphylococcus aureus and Acinetobacter baumannii that had been isolated in some of the samplings before PX-UV were no longer detected after t1, t2 and t5 treatments. Before PX-UV, the mean colony count was similar between t1 and t2 (p>0.05); after t3 and t4 treatments, it was lower before t5 in both the Orthopaedic and Neurosurgical operating rooms (= -97% and -75%, respectively; p<0,01). CONCLUSIONS: Implication for practice: PX-UV could supplement the standard cleaning process in reducing the microbial burden in the operating rooms and potentially achieving lower healthcare-associated surgical site infections rates.


Asunto(s)
Infección Hospitalaria , Desinfección , Humanos , Italia , Quirófanos , Estudios Prospectivos , Xenón
2.
Ann Ig ; 31(2): 181-185, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30714615

RESUMEN

We report the epidemiology of food-borne botulism in Puglia, Italy, between 1977-2017, using surveillance data and Experts' personal observations. As the disease is rare, the diagnosis is often missed or delayed, and cases are initially misdiagnosed. This was the case of a family outbreak of botulism in the 1970s.


Asunto(s)
Botulismo/epidemiología , Brotes de Enfermedades , Microbiología de Alimentos , Adolescente , Anciano de 80 o más Años , Botulismo/diagnóstico , Femenino , Humanos , Italia/epidemiología , Persona de Mediana Edad , Adulto Joven
3.
Ann Ig ; 30(6): 490-501, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30614498

RESUMEN

BACKGROUND: According to recent estimates, cervical cancer is worldwide the second most common cancer in females and the fourth overall. The number of deaths for cervical cancer is around 7.5% of all female cancer deaths. Cervical cancer is the only tumour with a known necessary cause, the HPV infection and, globally, HPV is the most common sexually transmitted infection. Two major approaches for cervical cancer prevention have been designed: primary prevention by HPV vaccination and secondary prevention by screening. The aim of our study is to design an overview of epidemiology, cost of the therapies and cost of prevention measures (screening and vaccines) 9 years after the introduction of anti-HPV vaccination in the Apulia Regional Immunization Program. STUDY DESIGN: Retrospective observational study. METHODS: To describe the epidemiology of cervical cancer, we analysed data from the Apulia regional archive of hospital discharge forms (SDO). We considered all records referred to cervical cancer using the ICD 9 code 180.xxx both in primary and secondary diagnosis, for the years 2007-2016. Subjects living in Apulia have been considered. Costs of hospitalization were computed considering generated Diagnosis Related Groups (DRG). To describe the Apulian screening program, we analysed data from Regional Screening Data warehouse; the cost of the single test was established according to the Tariff List from the Ministry of Health. Finally, vaccination data were extracted by Regional Immunization Database and official ex-factory price has been used to calculate the costs of immunization program. RESULTS: From 2007 to 2016, an important decrease in the incidence rate of cervical cancer in Apulia has been noted, ranging from 43.7 per 100,000 residents in 2007 to 21.0 per 100,000 residents in 2016. From an economic point of view, a clear reduction (39%) is observed in hospitalization costs over time. Total costs of prevention programs increased over time and globally exceed € 54,000,000, with a decreasing trend for vaccine prophylaxis and an increasing trend for screening. CONCLUSIONS: The incidence and costs of cervical cancer in Apulia, although already significantly decreasing, likely will be further reduced since 2027-2032, when we can observe the effects of vaccine prophylaxis on the burden of disease; on this occasion it will be also possible to quantify the actual cost-effectiveness of the vaccine. In our opinion, in the future the Apulia healthcare executives should enhance and improve the active screening test offer, without underestimating the importance of sexual education in young people, especially in those who have not had sexual debut yet.


Asunto(s)
Infecciones por Papillomavirus/prevención & control , Neoplasias del Cuello Uterino/epidemiología , Neoplasias del Cuello Uterino/prevención & control , Niño , Costos y Análisis de Costo , Grupos Diagnósticos Relacionados , Femenino , Hospitalización/economía , Hospitalización/estadística & datos numéricos , Humanos , Incidencia , Italia/epidemiología , Masculino , Tamizaje Masivo/economía , Tamizaje Masivo/métodos , Persona de Mediana Edad , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/complicaciones , Infecciones por Papillomavirus/diagnóstico , Vacunas contra Papillomavirus/economía , Prevención Primaria/economía , Estudios Retrospectivos , Prevención Secundaria/economía , Neoplasias del Cuello Uterino/diagnóstico , Neoplasias del Cuello Uterino/virología , Vacunación/economía
4.
J Prev Med Hyg ; 56(3): E112-5, 2015 Aug 31.
Artículo en Inglés | MEDLINE | ID: mdl-26788730

RESUMEN

Meningococcal disease is an acute, severe bacterial infection caused by Neisseria meningitidis. The most common presentations of invasive meningococcal infection (IMD) are meningitis and sepsis, less common pathologic presentations include focal infections. IMD can develop from initial symptoms to death within 24 hours. As many as 20% of survivors have permanent sequelae. Infants < 1 year of age have the highest incidence and adolescents the highest carriage prevalence. In Italy, the incidence of IMD was 0.25 confirmed cases per 100,000 in 2011, but this may have been considerably underestimated due to under-detection and under-reporting. Recently, we estimated the impact of the MenC universal vaccination on the burden of meningococcal meningitis in Puglia by assessing the completeness of three registration sources (notifications, hospitalizations, and laboratory surveillance). The sensitivity of the three systems was 36.7% (95% CI: 17.5%-57.9%) and registrations lost nearly 28 cases/year in the period 2001- 2013. In the National Surveillance of Invasive Bacterial Diseases, serogroup B accounted for 64.9% of samples serotyped in 2011. Applying this percentage to the total number of hospitalizations for IMD registered in the same year (n = 256), we obtained an estimated 166 episodes attributable to serogroup B. Our work highlights the importance of enhancing surveillance for meningococcal disease and strengthening vaccinations against all preventable serogroups.

5.
Ann Ig ; 27(6): 824-50, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26835797

RESUMEN

Recommendations for vaccination against rotavirus (RV) were issued in Apulia in 2006; the vaccine was free of charge to children who entered day care or nursery school by 1 year of age or those affected by chronic diseases for which diarrhea caused by rotavirus can increase the risk of complications and hospitalization. In 2014, vaccination became available to all healthy children with only a copayment. However, there has not been a significant increase in vaccination coverage. On April 17, 2015, Apulian public health physicians and paediatricians met to share strategies to promote the RV vaccine indications provided in the regional immunization schedule. During the meeting, presentation of data reports were interspersed with discussions that were led with a "bottom-up" approach. The discussants responded to pre-planned questions raised by the participants and encouraged by the discussion.


Asunto(s)
Gastroenteritis/diagnóstico , Gastroenteritis/prevención & control , Programas de Inmunización , Pediatría , Vacunas contra Rotavirus/administración & dosificación , Rotavirus , Vacunación , Preescolar , Consenso , Análisis Costo-Beneficio , Gastroenteritis/economía , Gastroenteritis/epidemiología , Gastroenteritis/virología , Humanos , Programas de Inmunización/métodos , Incidencia , Lactante , Italia/epidemiología , Tiempo de Internación/estadística & datos numéricos , Admisión del Paciente/estadística & datos numéricos , Salud Pública , Rotavirus/aislamiento & purificación , Vacunas contra Rotavirus/economía , Vacunación/economía , Vacunación/métodos
6.
Epidemiol Infect ; 142(2): 287-94, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23673019

RESUMEN

In this study we assessed the seroprevalence of hepatitis E virus (HEV) infection in both the Italian population and immigrants from developing countries in Foggia (Apulia, Southern Italy). The seroprevalence of HEV was determined in 1217 subjects [412 (34%) immigrants and 805 Italian subjects (blood donors, general population, HIV-positive, haemodialysis patients)]. Serum samples were tested for anti-HEV and confirmed by Western blot assay; in positive patients HEV RNA and genotype were also determined. There were 8·8% of patients that were positive to anti-HEV, confirmed by Western blot. The prevalence in immigrants was 19·7%, and in Italians 3·9% (blood donors 1·3%, general population 2·7%, HIV-positive patients 2·0%, haemodialysis patients 9·6%). Anti-HEV IgM was found in 38/107 (35·5%) of the anti-HEV-positive serum samples (34 immigrants, four Italians). This study indicates a higher circulation of HEV in immigrants and Italian haemodialysis patients, whereas a low prevalence of HEV antibodies was seen in the remaining Italian population.


Asunto(s)
Hepatitis E/epidemiología , Adulto , Anciano , Western Blotting , Emigrantes e Inmigrantes/estadística & datos numéricos , Femenino , Virus de la Hepatitis E , Humanos , Italia/epidemiología , Masculino , Persona de Mediana Edad , Prevalencia , Diálisis Renal/estadística & datos numéricos , Factores de Riesgo , Estudios Seroepidemiológicos
7.
Public Health ; 128(5): 438-43, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24856199

RESUMEN

OBJECTIVES: To describe an outbreak of acute gastroenteritis in people who had eaten at a hash house in southern Italy. STUDY DESIGN: Case-control study. METHODS: A clinical case of gastroenteritis was defined as a person who had eaten at the hash house from 29 August to 4 September 2011 and who experienced defined gastrointestinal symptoms within 72 hours, or a person with a laboratory-confirmed salmonella infection without symptoms. A convenience sample was enrolled as the control group. Environmental and human samples were collected, and Salmonella infantis was identified by polymerase chain reaction. Univariate analysis was performed for each food type, and multivariate analysis was performed for each food type and demographic variable (gender, age). RESULTS: Twenty-three cases of gastroenteritis were notified between 1 and 4 September 2011, two of which were admitted to the local hospital. Multivariate analysis showed that porchetta [odds ratio (OR) 22.0, 95% confidence interval (CI) 3.2-152.6, z = 3.13, P = 0.002] and roasted meat (OR 14.4, 95% CI 1.7-122.0, z = 2.45, P = 0.014) were associated with gastrointestinal symptoms. Environmental and human isolates exhibited the same sequence type (ST 32). CONCLUSIONS: This experience highlighted that, in the control of a foodborne outbreak, integrated epidemiological and laboratory surveillance enables rapid identification of the source of infection, thus reducing the risk of an epidemic.


Asunto(s)
Brotes de Enfermedades , Gastroenteritis/epidemiología , Restaurantes , Intoxicación Alimentaria por Salmonella/epidemiología , Salmonella enterica/aislamiento & purificación , Enfermedad Aguda , Adolescente , Adulto , Antibacterianos/uso terapéutico , Estudios de Casos y Controles , Niño , Notificación de Enfermedades , Heces/microbiología , Femenino , Análisis de los Alimentos/estadística & datos numéricos , Manipulación de Alimentos/normas , Gastroenteritis/tratamiento farmacológico , Gastroenteritis/etiología , Humanos , Italia/epidemiología , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Análisis Multivariante , Oportunidad Relativa , Reacción en Cadena de la Polimerasa , Vigilancia de la Población , Intoxicación Alimentaria por Salmonella/tratamiento farmacológico , Intoxicación Alimentaria por Salmonella/etiología , Encuestas y Cuestionarios , Adulto Joven
8.
Ann Ig ; 25(2): 145-50, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23471452

RESUMEN

BACKGROUND: The objective of this study is to describe the knowledge and skills of managers working in health organizations in the Region of Puglia (South of Italy) on the principles and tools of clinical governance. METHODS: A KAP (Knowledge, Attitudes and Practice) survey was conducted using a questionnaire. The target population of the survey was represented by Hospital Directors and Managers of local health care structures (Primary Care Districts, Public Health Departments, and Mental Health Departments). RESULTS: 92 managers participated at the study (response rate was 90.2%). 98.9% of respondents reported being aware of the concept of clinical governance and believe that clinical governance is an appropriate strategy for the continuous improvement in quality of services. 96.7% of respondents had heard of Evidence Based Practice and 80.6% reported using the method of EBP in nursing practice. The availability of guidelines for consultation was reported by 54.9% of respondents. Of those interviewed, 79.8% knew about Health Technology Assessment. 95.5% reported they have heard of clinical audit and 98.9% knowing the concept of risk management. CONCLUSION: In our survey, an high value judgment about clinical governance was reported by medical managers. The lower attitudes towards the use of the tools of clinical governance highlights an important discrepancy with respect to knowledge and opinions, which becomes more evident in community care structures. Above and beyond training managers, it is also necessary to change training methods used on all health personnel, which should be oriented towards EBM in order to build an adaptable organizational climate.


Asunto(s)
Gestión Clínica , Administradores de Instituciones de Salud/psicología , Conocimientos, Actitudes y Práctica en Salud , Auditoría Administrativa , Competencia Profesional , Actitud del Personal de Salud , Auditoría Clínica , Práctica Clínica Basada en la Evidencia , Femenino , Encuestas de Atención de la Salud , Administradores de Hospital/psicología , Humanos , Italia , Masculino , Servicios de Salud Mental/organización & administración , Persona de Mediana Edad , Guías de Práctica Clínica como Asunto , Atención Primaria de Salud/organización & administración , Administración en Salud Pública , Garantía de la Calidad de Atención de Salud , Gestión de Riesgos , Encuestas y Cuestionarios , Evaluación de la Tecnología Biomédica
9.
Ann Ig ; 25(2): 109-18, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23471448

RESUMEN

BACKGROUND: A point prevalence survey (PPS) was conducted in Italy in 2010, as part of the first European PPS in Long Term Care Facilities (LTCFs), conducted within the HALT Project. METHODS: The PPS was aimed at estimating the prevalence of infections, antimicrobial resistance, and antibiotic use and to assess the status of infections control programs in this setting. RESULTS: Ninety two LTCFs, located in 11 different Italian regions, participated to the study: 9391 residents were enrolled, 9285 of whom were eligible according to the study criteria. The prevalence of residents with signs/symptoms of infection was 6.5% (606 residents); 438 residents were on antimicrobial treatment (4.7%) and 526 had signs/symptoms (5.7%) but in 324 residents only (3.5/100 residents) the infection satisfied the modified McGeer criteria and was considered confirmed. The most frequent infection site was the respiratory tract (1.27/100 residents). Mostly of the antibiotics were prescribed for respiratory tract infections (42.8% of the antibiotics) and for urinary tract infections (26.6%). The most frequently prescribed classes were quinolones, followed by penicillin plus beta-lactamase inhibitor and 3rd generation cephalosporins. Few infection had a microbiological confirmation, but among the 143 isolated microorganisms 24% were multidrug resistant. CONCLUSIONS: The burden of infections and antimicrobial resistance in LTCFs is significant and infection control and surveillance program are urgently needed.


Asunto(s)
Infección Hospitalaria/epidemiología , Farmacorresistencia Bacteriana , Encuestas Epidemiológicas , Hogares para Ancianos/estadística & datos numéricos , Institucionalización/estadística & datos numéricos , Cuidados a Largo Plazo , Casas de Salud/estadística & datos numéricos , Anciano , Anciano de 80 o más Años , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Bacterias/efectos de los fármacos , Bacterias/aislamiento & purificación , Técnicas Bacteriológicas/estadística & datos numéricos , Infección Hospitalaria/tratamiento farmacológico , Infección Hospitalaria/microbiología , Farmacorresistencia Bacteriana Múltiple , Utilización de Medicamentos/estadística & datos numéricos , Femenino , Hogares para Ancianos/organización & administración , Humanos , Control de Infecciones/organización & administración , Italia/epidemiología , Cuidados a Largo Plazo/organización & administración , Masculino , Casas de Salud/organización & administración , Vigilancia de la Población , Prevalencia , Factores de Riesgo , Encuestas y Cuestionarios
11.
Ann Ig ; 24(3): 191-6, 2012.
Artículo en Italiano | MEDLINE | ID: mdl-22834247

RESUMEN

In Italy there have been several court appeals registered, which have been driven by individual convictions or group actions or movements and were aimed at obtaining exemption from the obligation to comply with compulsory vaccinations required by law. The aim of the present paper is to provide a quick review of the sentences resulting from activating these disputes, in order to contribute to the debate on overturning compulsory vaccination. The Jurisprudence of the Italian Constitutional Court has repeatedly confirmed the judgment on the constitutionality of rules on obligation, clarifying that only where specific reasons exist that make vaccinating the individual dangerous may non-compliance with the rules on compulsory vaccination be justified. This is in contrast with the case law on enforcement of compulsory vaccination, through the temporary suspension of parental authority. Taking responsibility for promoting immunisation decisions away from Public Health Services and handing it to the courtroom is not advisable, given the very small benefit. The problem must be placed under the careful attention of the Health Service due to communicative implications, which can be serious during the transition from a compulsory system of immunisation to a voluntary one.


Asunto(s)
Derechos Humanos/legislación & jurisprudencia , Práctica de Salud Pública/legislación & jurisprudencia , Vacunación/legislación & jurisprudencia , Humanos , Italia
12.
Int J Immunopathol Pharmacol ; 24(2): 423-32, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21658316

RESUMEN

Cystic Fibrosis (CF) lung disease is characterized by high levels of cytokines and chemokines in the airways, producing chronic inflammation. Non-invasive biomarkers, which are also specific for the inflammatory and immune responses, are urgently needed to identify exacerbations and evaluate therapeutic efficacy. The aim of this study is to evaluate the association of sputum and exhaled breath condensate (EBC) biomarker changes with clinical exacerbation and response to therapy. We studied the simultaneous presence and concentration of twelve cytokines and growth factors (EGF, IL-1alpha, IL-1beta, IL-2, IL-4, IL-6, IL-8, IL-10, IFN-gamma, MCP-1, TNF-alpha and VEGF) by a multi-parametric biochip array in sputum and EBC of 24 CF patients before, after 6 and 15 days of therapy, and 15 days after the end of treatment for an acute exacerbation. Correlations with functional respiratory tests (FEV1, FVC) and the systemic marker C-reactive protein (CRP) were looked for. In sputum, before therapy, VEGF and IL-1beta levels positively correlated with the respiratory function and CRP. Sputum IL-1alpha, IL-1beta IL-4, IL-10, TNF-alpha, and VEGF significantly decreased, while EGF increased, during therapy. IL-8 and IL-4 levels negatively correlated with the respiratory function at 15 and 30 days from the start of therapy, respectively. IL-4, IL-6, IL-10 and TNF-alpha positively correlated with CRP during therapy. Although some EBC biomarkers correlated with respiratory function and CRP, no significant associations with these clinical parameters were found. Sputum IL-1beta and VEGF might be considered biomarkers of an acute exacerbation in CF patients. A panel of sputum cytokines and growth factors may better describe the response to intravenous antibiotic treatment of CF than one single systemic marker.


Asunto(s)
Pruebas Respiratorias , Fibrosis Quística/diagnóstico , Citocinas/metabolismo , Espiración , Mediadores de Inflamación/metabolismo , Péptidos y Proteínas de Señalización Intercelular/metabolismo , Análisis por Matrices de Proteínas , Proteómica/métodos , Esputo/inmunología , Antibacterianos/uso terapéutico , Biomarcadores/metabolismo , Fibrosis Quística/tratamiento farmacológico , Fibrosis Quística/inmunología , Fibrosis Quística/fisiopatología , Volumen Espiratorio Forzado , Humanos , Italia , Modelos Lineales , Pulmón/inmunología , Pulmón/fisiopatología , Valor Predictivo de las Pruebas , Factores de Tiempo , Resultado del Tratamiento , Capacidad Vital
13.
J Prev Med Hyg ; 52(4): 219-23, 2011 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22442929

RESUMEN

INTRODUCTION: The aim of the present study is to determine attitude and associated factors towards the use of methods of protection/contraception. METHODS: In August 2008, a study was carried out using a self-administered standardised anonymous questionnaire. It was administered to school-leavers who were attending a study course at Bari University. RESULTS: The total number of questionnaires returned was 1091, the average age of the interviewed subjects was 19.6. Those declaring to have had sexual intercourse at least once was 88%. Of those sexually active, the average age at first intercourse was 16.8, and 75.2% stated that they had used some form of contraception on this occasion. The condom was the most popular method employed, followed by withdrawal and by contraceptive pills. Around 20% of the interviewees indicated that they used emergency post-coital contraception. DISCUSSION: The study results emphasise the importance of an effective teaching of the aspects of sex and relationship education before puberty.


Asunto(s)
Conducta Anticonceptiva/estadística & datos numéricos , Conducta Sexual/estadística & datos numéricos , Estudiantes/estadística & datos numéricos , Adolescente , Adulto , Coito Interrumpido , Condones/estadística & datos numéricos , Anticoncepción Postcoital/estadística & datos numéricos , Anticonceptivos Orales , Femenino , Humanos , Italia , Modelos Logísticos , Masculino , Factores Sexuales , Parejas Sexuales , Encuestas y Cuestionarios , Universidades , Adulto Joven
14.
Ann Ig ; 23(2): 93-9, 2011.
Artículo en Italiano | MEDLINE | ID: mdl-21770225

RESUMEN

The 1853 Vaccination Act, adopted in England during XIX century, was the first law about compulsory vaccination in Europe. The Act caused a violent movement of opposition with the birth of Victorian anti-vaccination. The modern anti-vaccination movement was born in 1998 following a paper of Andrew Wakefield published in the Lancet. In this paper Wakefield illustrated a study of twenty patients and concluded that the administration of the MMR vaccine caused autism and some forms of colitis. The publication was later disowned by almost all authors. However the study of Wakefield caused a reduction of compliance to the anti-MMR vaccination in the United Kingdom, resulting in lower coverage and new outbreaks. The theorethical principles of anti-vaccinationists of 19th and 20th century were: the hypothesis that vaccines cause illnesses; the presence of toxic substances in the vaccine; the violation of freedom Personal and People's; the ineffectiveness of vaccinations. Moreover, anti-vaccinationists always refused the scientific methods and the peer-review of their scientific studies.


Asunto(s)
Medicina Basada en la Evidencia , Vacunación Masiva/historia , Vacunación/historia , Trastorno Autístico/etiología , Trastorno Autístico/historia , Negación en Psicología , Europa (Continente) , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Programas Obligatorios/historia , Medios de Comunicación de Masas/historia , Vacunación Masiva/legislación & jurisprudencia , Vacuna contra el Sarampión-Parotiditis-Rubéola/historia , Autonomía Personal , Conservadores Farmacéuticos/historia , Salud Pública/historia , Reino Unido , Vacunación/efectos adversos , Vacunación/legislación & jurisprudencia
16.
Allergy ; 65(10): 1306-12, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20557302

RESUMEN

BACKGROUND: Female hormones play an important role in women's lung health, especially in asthma pathophysiology. Although a growing interest has recently been aroused in asthma related to short-term reproductive states, menopausal asthma has been little studied in the past. The aim of the present study was to explore airway inflammation in menopausal asthmatic women in a noninvasive manner. METHODS: Forty consecutive women with menopausal asthma, 35 consecutive women with premenopausal asthma and 30 age-matched healthy controls were enrolled in the study. Urinary LTE-4, induced sputum inflammatory cells, and exhaled LTE-4, IL-6, pH, and NO levels were measured in all the subjects enrolled. RESULTS: Women with menopausal asthma showed decreased estradiol concentrations, high sputum neutrophils, and exhaled IL-6. Women with premenopausal asthma presented instead an essentially eosinophilic inflammatory pattern. Higher urine and breath condensate LTE-4 concentrations were found in premenopausal and menopausal asthma compared to controls. CONCLUSION: Our results substantiate the existence of a new biological phenotype of menopausal asthma that is mainly characterized by neutrophilic airways inflammation and shares several characteristics of the severe asthma phenotype.


Asunto(s)
Asma , Menopausia , Asma/patología , Asma/fisiopatología , Estudios de Casos y Controles , Eosinófilos , Espiración , Femenino , Humanos , Concentración de Iones de Hidrógeno , Inflamación/patología , Interleucina-4/análisis , Leucotrieno E4/análisis , Leucotrieno E4/orina , Persona de Mediana Edad , Neutrófilos/patología , Óxido Nítrico/análisis , Fenotipo , Premenopausia , Esputo
17.
Euro Surveill ; 15(1)2010 Jan 07.
Artículo en Inglés | MEDLINE | ID: mdl-20067748

RESUMEN

A nosocomial outbreak of 2009 pandemic influenza A(H1N1), with eight confirmed cases, occurred in a paediatric oncology ward in Italy, in October/November 2009. The fact that one case was infected despite being isolated and without contact to a symptomatic patient, hints towards potential transmission through a health care worker (HCW) and underlines the importance of vaccination of HCW who are involved in the care of critically ill patients.


Asunto(s)
Infección Hospitalaria , Brotes de Enfermedades , Subtipo H1N1 del Virus de la Influenza A , Gripe Humana/epidemiología , Adolescente , Niño , Preescolar , Enfermedad Crítica , Hospitales , Humanos , Lactante , Vacunas contra la Influenza/administración & dosificación , Pacientes Internos , Italia/epidemiología , Oncología Médica , Aislamiento de Pacientes , Habitaciones de Pacientes
18.
Ig Sanita Pubbl ; 66(5): 659-70, 2010.
Artículo en Italiano | MEDLINE | ID: mdl-21135907

RESUMEN

The aim of this study is to describe the immunization strategies for 23-valent pneumococcal vaccine in the Italian regions. Sixteen regions offer pneumococcal vaccine to elderly people and 18 regions to risk groups. Nine among them offer the vaccine free of charge and perform the call for immunization. Five regions created a database of the risk groups. Data about vaccination coverage are available for seven regions; in the other only the number of administered doses is collected yearly. Different immunization strategies may represent a determinant of health inequalities.


Asunto(s)
Inmunización/estadística & datos numéricos , Vacunas Neumococicas , Anciano , Humanos , Italia , Persona de Mediana Edad , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA